Belpointe Asset Management »

Atyr Pharma shares owned by Belpointe Asset Management

Quarter-by-quarter ownership of Atyr Pharma (ATYR) shares owned by Belpointe Asset Management from 13F filings

Historical chart of Belpointe Asset Management investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by Belpointe Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by Belpointe Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.5k 10k 0.72

More positions owned by Belpointe Asset Management

Servicenow (NOW)
NVIDIA Corporation (NVDA)
Invesco QQQ Trust Etf (QQQ)
Spdr S&p 500 Etf Etf (SPY)
Apple (AAPL)
Schwab Strategic Tr Etf (SCHG)
Collaborative Investmnt Ser Etf (NDOW)
Microsoft Corporation (MSFT)
Ishares Tr Etf (SGOV)
Schwab Strategic Tr Etf (SCHX)
Sch Fnd Us Lg Etf schwb fdt us lg (FNDX)
Vanguard S&P 500 ETF Etf (VOO)
Badger Meter (BMI)
Vanguard Index Fds Etf (VUG)
Amazon (AMZN)

View all positions for Belpointe Asset Management

Top funds holding Atyr Pharma

FMR
Federated Investors
BlackRock
Vanguard Group
UBS Group
State Street Corporation
Geode Capital Management
Affinity Asset Advisors
Millennium Management
Susquehanna International
Rosalind Advisors
Artia Global Partners
Jane Street
Citadel Advisors
GSA Capital Partners

View all funds holding Atyr Pharma